This Heart Drug Was Written Off — Now Amarin (AMRN) Is Back in the Game
Founded with the goal of addressing unmet needs in cardiovascular health through rigorous science rather than incremental reformulations,…
Amarin (AMRN) Posts 17% Revenue Surge: Is This the Start of a Massive Turnaround?
Amarin Corporation plc (NASDAQ:AMRN) has evolved into one of the most closely watched companies in the global cardiovascular…